Monoclonal antibody successes in the clinic.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16151394.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most monoclonal antibodies in clinical trials are owned by small biotech companies. But with blockbuster-sized revenues and approval rates higher than those for small-molecule drugs, that all may be set to change.
Medical subject headings
- Antibodies, Monoclonal
- Immunotherapy